Mathieu Bernard Mari Charveriat
Fortune : 2 M $ au 31/08/2026
Fortune : 2 M $ au 31/08/2026
Mathieu Bernard Mari Charveriat is the founder of Theranexus SA, serving as Chairman & Chief Executive Officer since 2014.
Former job includes a position as Member at Signia Therapeutics SAS. Education includes a doctorate from Université Pierre et Marie Curie and an undergraduate degree from Ecole Polytechnique.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
THX PHARMA 2,29% | 30/06/2026 | 331 576 ( 2,29% ) | 2 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| THX PHARMA | Directeur Général | 01/01/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Signia Therapeutics SAS
Signia Therapeutics SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ecole Polytechnique
Ecole Polytechnique Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theranexus SA
Theranexus SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for treatment of central nervous system diseases | Health Technology |
Signia Therapeutics SAS
Signia Therapeutics SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national